跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COZAAR XQ - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
COZAAR XQ
Approved
STANDARD
COZAAR XQ
Hanmi Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0bf38752b5a7d00c
Company
Hanmi Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
0bf38752b5a7d00c
Drug Approval Philippines Name
COZAAR XQ
Product Name
COZAAR XQ
Registration Number
DR-XY40907
Brand Name
COZAAR XQ
Generic Name
Losartan Potassium + Amlodipine camsylate
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg/5 mg
Manufacturer
Hanmi Pharmaceutical Co., Ltd.
Importer
Merck Sharp & Dohme (I.A.) LLC
Company Detail Path
/organization/hanmi-pharmaceutical-co-ltd
Issuance Date
26 April 2025
Expiry Date
17 May 2031
Pharmacologic Category
Antihypertensive (Angiotensin II Receptor Blocker - Calcium Channel Blocker Combination
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0bf38752b5a7d00c
Type
Standard
Back to Philippines FDA Approvals